Interestingly, the carriers of the PNPLA3 I148M variant have a substantial increased risk in cirrhosis and hepatocellular carcinoma [66, 67, 75–84] independently of the predisposition to steatosis. The gene discussed is PNPLA3; the disease is hepatocellular carcinoma.